Data as of June 1, 2026
This table displays the countermeasure and injury for claims that are eligible for compensation, and that the program is either waiting for documentation from the requester to determine benefits or benefits determination is in progress.
Please note that the number column within the tables are not assigned numbers for a particular claim, but reflect the number of listed items in a given table. Further details concerning the table contents are provided below.
Additional changes have been made to reflect the correct covered injury, rather than the alleged injury, for those claims pending compensation.
| Number | Covered Countermeasure | Covered Injury |
|---|---|---|
| 1 | COVID-19 Vaccine | Guillain-Barré Syndrome (GBS) |
| 2 | COVID-19 Vaccine | Myocarditis |
| 3 | COVID-19 Vaccine | Myopericarditis |
| 4 | COVID-19 Vaccine | Myocarditis |
| 5 | COVID-19 Vaccine | Myocarditis |
| 6 | COVID-19 Vaccine | Myocarditis |
| 7 | COVID-19 Vaccine | Myocarditis |
| 8 | COVID-19 Vaccine | Guillain-Barré Syndrome (GBS) |
| 9 | COVID-19 Vaccine | Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) |
| 10 | COVID-19 Vaccine | Myopericarditis |
| 11 | COVID-19 Vaccine | Myocarditis |
| 12 | COVID-19 Vaccine | Myopericarditis |
| 13 | COVID-19 Vaccine | Myocarditis |
| 14 | COVID-19 Vaccine | Myocarditis |
| 15 | COVID-19 Vaccine | Myocarditis |
| 16 | COVID-19 Vaccine | Myocarditis |
| 17 | COVID-19 Vaccine | Myocarditis |
| 18 | COVID-19 Vaccine | Myocarditis |
| 19 | COVID-19 Vaccine | Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) |
| 20 | COVID-19 Vaccine | Myocarditis |
| 21 | COVID-19 Vaccine | Myocarditis |
| 22 | COVID-19 Vaccine | Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) |
| 23 | COVID-19 Vaccine | Myopericarditis |
| 24 | COVID-19 Vaccine | Myocarditis |
| 25 | COVID-19 Vaccine | Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) |
| 26 | COVID-19 Vaccine | Myocarditis |
| 27 | COVID-19 Vaccine | Myopericarditis |
| 28 | COVID-19 Vaccine | Myocarditis |
| 29 | COVID-19 Vaccine | Myocarditis |
| 30 | COVID-19 Vaccine | Guillain-Barré Syndrome (GBS) |
| 31 | COVID-19 Vaccine | Thrombotic Thrombocytopenia Syndrome (TTS) |
| 32 | COVID-19 Vaccine | Myocarditis |
| 33 | COVID-19 Vaccine | Myocarditis |
| 34 | COVID-19 Vaccine | Guillain-Barré Syndrome (GBS) |
| 35 | COVID-19 Vaccine | Guillain-Barré Syndrome (GBS) |
| 36 | COVID-19 Vaccine | Myocarditis |
| 37 | COVID-19 Vaccine | Myopericarditis |
| 38 | COVID-19 Vaccine | Myopericarditis |
| 39 | COVID-19 Vaccine | Myocarditis |
| 40 | COVID-19 Vaccine | Myocarditis |
| 41 | COVID-19 Vaccine | Myocarditis |
| 42 | COVID-19 Vaccine | Myocarditis |
| 43 | COVID-19 Vaccine | Myocarditis |
| 44 | COVID-19 Vaccine | Myocarditis |
| 45 | COVID-19 Vaccine | Myocarditis |
Date Last Reviewed: